logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Mina Therapeutics Announces Equity Investment From Lilly

Jul 06, 2021over 4 years ago
London

Description

MiNA Therapeutics Limited (“MiNA” or the “Company”), the pioneer in small activating RNA therapeutics, announces that Eli Lilly and Company has entered into a definitive agreement under which it will make a direct equity investment in MiNA.

Company Information

Company

Mi Na Therapeutics

Location

London, Ontario, Canada

About

MiNA Therapeutics is the leader in small activating RNA therapeutics. Harnessing innate mechanisms of gene activation, small activating RNA therapeutics are a revolutionary new class of medicines that can restore or boost normal function in patients' cells. We are advancing a proprietary pipeline of new medicines with an initial focus on cancer and genetic diseases, while collaborating with leading pharmaceutical companies to apply our technology platform across a broad range of therapeutic areas. Based on our unique know-how in RNA activation we are expanding the possibilities of RNA-based medicine for patients. www.minatx.com

Related People

3 contacts

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details